Sort
326,823 grants matching “clinical trial”
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,384,337David A Barbie · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Therapies for patients with rare tumors and genetic tumor predisposition
$2,384,333Brigitte Widemann · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Connecting the Dots: An RCT Integrating Standardized ASD Screening, High-Quality Treatment, and Long-Term Outcomes
$2,384,316Diana L Robins · Drexel University · R01 · FY2017 · MH
DETERMINING WHAT IS RIGHT FOR WHOM: A HYBRID EXPERIMENTAL CLINICAL TRIAL OF TAILORED INTERVENTION SEQUENCING TO MAXIMIZE EFFECTIVENESS OF PTSD TREATMENT
$2,384,097The University Of Texas Health Science Center At San Antonio · · FY2024 · Defense Health Agency
LIPS-A: Lung Injury Prevention Study with Aspirin
$2,384,003Ognjen Gajic · Mayo Clinic Rochester · U01 · FY2012 · HL
Stem Cell Gene Therapy for Hemoglobinopathies
$2,383,844George Stamatoyannopoulos · University Of Washington · P01 · FY2011 · HL
Stem Cell Gene Therapy for Hemoglobinopathies
$2,383,844George Stamatoyannopoulos · University Of Washington · P01 · FY2012 · HL
Novel Therapies to Modulate the Inflammatory Alloresponse in Renal Grafts
$2,383,582Flavio Vincenti · University Of California, San Francisco · U01 · FY2016 · AI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,383,303Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2020 · CA
Metro-Minnesota Community Clinical Oncology Program
$2,383,276Patrick James Flynn · Park Nicollet Institute · U10 · FY2010 · CA
Cancer Center Support Grant
$2,383,262Michael J Weber · University Of Virginia · P30 · FY2012 · CA
SPORE in Prostate Cancer
$2,383,257Peter T Scardino · Sloan-Kettering Inst Can Research · P50 · FY2006 · CA
DEFUSE 3: EnDovascular ThErapy Following Imaging EvalUation for ISchemic StrokE 3
$2,383,083Gregory W Albers · Stanford University · U01 · FY2016 · NS
GENERAL CLINICAL RESEARCH CENTER
$2,383,063University Of Texas Medical Br Galveston · M01 · FY2002 · RR
ECOG Statistical Office
$2,382,969Robert J Gray · Dana-Farber Cancer Inst · U10 · FY2010 · CA
NEW APPROACHES TO SURGICAL ONCOLOGY
$2,382,667John Wayne Cancer Institute · P01 · FY2001 · CA
Botswana-Harvard School of Public Health AIDS Initiative Partnership CTU
$2,382,602Myron E Essex · Harvard School Of Public Health · UM1 · FY2014 · AI
Pelvic floor Disorders Network-Data Coordinating Center
$2,382,584Morton B. Brown · University Of Michigan At Ann Arbor · U01 · FY2006 · HD
Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,382,404Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2020 · CA
Pitt-Ohio State Clinical Trials Unit
$2,382,302Sharon Riddler · University Of Pittsburgh At Pittsburgh · UM1 · FY2025 · AI
Institutional Clinical and Translational Science Award (UW-Madison)
$2,382,296Marc K. Drezner · University Of Wisconsin-Madison · KL2 · FY2009 · RR
NICOTINE DEPENDENCE: RISK &RECOVERY OVER GENERATIONS
$2,382,068Miriam Hospital · P50 · FY2000 · CA
Lung Vascular Disease in Infants and Children: Mechanisms and Treatment
$2,381,638Kurt R Stenmark · University Of Colorado Denver · P50 · FY2009 · HL
A Gene therapeutic approach to stable suppression of HIV-1 replication
$2,381,501Michael R. Farzan · Scripps Florida · P01 · FY2016 · AI
Multi-organ human-on-a-chip system to address overdose and acute and chronic efficacy and off-target toxicity
$2,381,424James J Hickman · University Of Central Florida · UH3 · FY2021 · TR